Study Stopped
Principal Investigator left
Patient Navigation and Tailored Treatment Planning in Latina Patients With Breast Cancer
Breast Cancer Patient Navigation and Tailored Treatment Planning: A Process Evaluation Study for LAC+USC Patient Navigation, Treatment Planning, and Ongoing Support for Latina Women
3 other identifiers
observational
13
1 country
1
Brief Summary
This research trial studies how well patient navigation and tailored treatment planning work in Latina patients with breast cancer. Patient navigation and tailored treatment planning may provide extra support by guiding patients through the healthcare system, remove barriers to care and provide ease of access to essential resources, encourage patient participation in their care, provide in-language summaries and plans for follow-up care, improve patient access to needed supportive care services and may improve general healthcare experience in Latina patients with breast cancer.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for all trials
Started Mar 2015
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
March 5, 2015
CompletedFirst Submitted
Initial submission to the registry
June 24, 2015
CompletedFirst Posted
Study publicly available on registry
June 26, 2015
CompletedPrimary Completion
Last participant's last visit for primary outcome
February 7, 2017
CompletedStudy Completion
Last participant's last visit for all outcomes
February 7, 2017
CompletedApril 20, 2017
April 1, 2017
1.9 years
June 24, 2015
April 18, 2017
Conditions
Keywords
Outcome Measures
Primary Outcomes (5)
Number of missed appointments from the time of initial diagnosis to the completion of primary treatment (chemotherapy, surgery and radiation as applicable) as measured by CCCQ
Questionnaire scores will be expressed as median values with 95% confidence intervals.
Up to 12 months
Number of patients enrolled on clinical trials (interventional and non-interventional)
Number of patients enrolled on clinical trials (interventional and non-interventional) will be quantified and compared to historical controls.
Up to 12 months
Number of special referrals made
Number of special referrals made (eg. social worker, genetic counseling, fertility) through the navigation system will quantified and compared to historical controls.
Up to 12 months
Overall experience with breast cancer (broadly) and at LAC+USC as measured by experience-based questionnaire
Up to 12 months
Usefulness, accessibility, and quality of the patient navigation model as measured by Continuity/Coordination of Care Questionnaire (CCCQ)
Means and standard deviations will be summarized per outcome measures at 3, 6, and 12 months after baseline, and 95% confidence intervals for the difference in means will be calculated for each assessment time for total scores and subscale scores.
Up to 12 months
Study Arms (1)
Observational (treatment summaries and plan report)
Patients receive treatment summaries and plan report that captures patient data through the use of an "intake checklist" completed during the initial consultation with the breast oncology team and used to guide referrals to existing services and programmed with generic information related to disease and treatment management plan. Additional elements, such as psycho-social services, exercise, and/or nutrition, identified by the patient self-report, will be incorporated. Patients also complete 3 questionnaires at each clinic visit.
Interventions
Ancillary studies
Complete questionnaires
Eligibility Criteria
Self-identified Latina (or Hispanic) who is receiving ongoing care at LAC+USC Medical Center will be recruited.
You may qualify if:
- Patients receiving ongoing care at LAC+USC
- Self-identified as Latina (or Hispanic)
- Known or suspected breast cancer
- Being seen in a breast cancer high risk, screening or prevention program or clinic or in one of the breast cancer clinics (surgical or medical oncology)
You may not qualify if:
- Inability to sign informed consent or complete questionnaires and forms
- Self-identified as non-Latina (or non-Hispanic)
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- University of Southern Californialead
- National Cancer Institute (NCI)collaborator
Study Sites (1)
USC / Norris Comprehensive Cancer Center
Los Angeles, California, 90033, United States
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Heather Macdonald
University of Southern California
Study Design
- Study Type
- observational
- Observational Model
- CASE ONLY
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
June 24, 2015
First Posted
June 26, 2015
Study Start
March 5, 2015
Primary Completion
February 7, 2017
Study Completion
February 7, 2017
Last Updated
April 20, 2017
Record last verified: 2017-04